コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 RA signaling were partially mediated by the retinoid X receptor.
2 ) could be bound by vitamin D receptor (VDR)/retinoid X receptor.
3 and involves direct interaction with RAR and retinoid X receptor.
4 and was dependent upon dimerization with the retinoid X receptor.
5 ein modification and heterodimerization with retinoid X receptor.
6 tor, and their obligate heterodimer partner, retinoid X receptor.
7 LXRs or their heterodimerizing partner, the retinoid X receptor.
8 overexpression of its heterodimeric partner, retinoid X receptor.
9 e PLA2g2a promoter as a heterodimer with the retinoid X receptor.
10 elements and for heterodimerization with the retinoid X receptors.
11 embers of retinoic acid receptors (RARs) and retinoid X receptors.
12 (negative association), and liver X receptor/retinoid X receptor activation (positive association).
13 mined the neuronally directed effects of the retinoid X receptor agonist bexarotene in an aggressive
14 and a panel of retinoid acid receptor (RAR)/retinoid X receptor agonist treatments suggested that RA
15 We investigated the effects of bexarotene (a retinoid X receptor agonist), CD1530 (a retinoic acid re
20 port that Nuclear receptor-related 1 (Nurr1):Retinoid X receptor alpha (RXRalpha) activation has a do
21 three closely related human NRs--HNF4alpha, retinoid X receptor alpha (RXRalpha) and COUPTF2--reveal
22 way that strongly inhibits the expression of retinoid X receptor alpha (RXRalpha) and suppresses the
24 tor activated receptor-gamma (PPARgamma) and retinoid X receptor alpha (RXRalpha) complex was found t
27 sactivation of BSEP and SHP promoters by FXR/retinoid X receptor alpha (RXRalpha) in HepG2 cells.
29 r partner to class II nuclear receptors, the retinoid X receptor alpha (RXRalpha) plays a vital physi
30 93T, it was possible to demonstrate that the retinoid X receptor alpha (RXRalpha) plus its ligand can
31 epatocyte nuclear factor 4alpha (HNF4alpha), retinoid X receptor alpha (RXRalpha) plus peroxisome pro
32 ediated by hepatocyte nuclear factor 4alpha, retinoid X receptor alpha (RXRalpha) plus peroxisome pro
33 tocyte nuclear factor 4alpha (HNF4alpha) and retinoid X receptor alpha (RXRalpha) plus peroxisome pro
34 ptors hepatocyte nuclear factor 4 (HNF4) and retinoid X receptor alpha (RXRalpha) plus peroxisome pro
35 s predicted to interact efficiently with VDR-retinoid X receptor alpha (RXRalpha) was identified in s
36 pharmacologically perturbed the activity of retinoid X receptor alpha (RXRalpha), a key hub within t
39 ctive homodimers to active heterodimers with retinoid X receptor alpha (RXRalpha), and phosphorylatio
40 depends on vitamin A signals mediated by the retinoid X receptor alpha (RXRalpha), as the systemic mu
42 interact in an agonist-dependent manner with retinoid X receptor alpha (RXRalpha), suggesting that th
43 Pbeta), forkhead box protein A2 (FOXA2), and retinoid X receptor alpha (RXRalpha), were markedly decr
44 ln275, Arg316 and Arg371 in nuclear receptor retinoid X receptor alpha (RXRalpha), where berberine co
45 xisome proliferator-activated receptor alpha-retinoid X receptor alpha (RXRalpha), with which PGC-1be
49 onstitutive androstane receptor (CAR, NR1I3)/retinoid X receptor alpha (RXRalpha, NR2B1) heterodimer
50 mation weight matrix for vitamin D3 receptor/retinoid X receptor alpha (VDR/RXRalpha) binding sites w
53 charide/Interleukin 1 mediated inhibition of Retinoid X Receptor alpha function and decreased Retinoi
56 d to this site as a monomer, because neither retinoid X receptor alpha nor retinoid X receptor beta a
57 Ralpha, induced the recruitment of PPARalpha:retinoid x receptor alpha, but not PPARgamma coactivator
58 stored the DNA binding activity of PPARalpha/retinoid X receptor alpha, induced mRNA levels of PPARal
59 itation studies confirmed the recruitment of retinoid X receptor alpha, PPARalpha, and PGC1alpha on t
63 istent with this suggestion, it appears that retinoid X receptor alpha/farnesoid X receptor alpha and
67 r expression of vitamin D receptor (VDR) and retinoid X receptor-alpha (RXR) has not been investigate
71 ing protein-alpha (Cebpalpha), Cebpbeta, and retinoid x receptor-alpha (Rxralpha) compared with untre
73 how here that keratinocytic nuclear receptor retinoid X receptor-alpha (RXRalpha) regulates mouse ker
75 brate drugs were abrogated in the absence of retinoid X receptor-alpha (RXRalpha), a molecule known t
76 n availability as hepatic nuclear PPARgamma, retinoid X receptor-alpha (RXRalpha), and PPARgamma/RXRa
81 specific target genes.The vitamin D receptor/retinoid X receptor-alpha heterodimer (VDRRXRalpha) regu
85 pha, but were decreased in mice deficient in retinoid X receptor-alpha, the major heterodimerization
86 ith a selective PPARgamma antagonist or with retinoid X receptor and retinoic acid receptor ligands p
87 clear receptors that heterodimerize with the retinoid X receptor and then modulate at the transcripti
88 ediated by preferential interactions between retinoid X receptors and CYP4F promoter elements in epid
89 inoic acid receptors (retinoic acid receptor/retinoid X receptor) and glucocorticoid receptors are re
90 Sult2A1 chromatin to recruit VDR, RXR-alpha (retinoid X receptor) and PXR in mice injected with D(3)
91 lets, also in vitro translated PPARgamma and retinoid X receptor, and chromatin immunoprecipitation a
93 by nuclear receptors retinoic acid receptor, retinoid X receptor, and thyroid hormone receptor and in
94 ic identity were linked to RUNX2, C/EBPbeta, retinoid X receptor, and vitamin D receptor binding site
95 th retinoic acid receptor, does not activate retinoid-X receptor, and is not a substrate for CYP26s,
96 unctional expression cloning approach, a gag-retinoid X receptor beta (gag-RXRbeta) fusion protein wa
98 ecause neither retinoid X receptor alpha nor retinoid X receptor beta antibody supershifted the prote
99 nscription factors PPARalpha, PPARdelta, and retinoid X receptor beta; and (c) liver development asso
100 , all found in the MHC class III region; and retinoid X receptor, beta (RXRB),which resides in the MH
102 21 gene transcription was mediated by an FXR/retinoid X receptor binding site in the 5'-flanking regi
103 ites identified two vitamin D receptor (VDR)/retinoid X receptor binding sites in the 1-kb promoter r
104 s 1,25(OH)(2)D(3) induces rapid VDR and RXR (retinoid X receptor) binding to the Cyp24a1 gene in both
105 adipocyte differentiation favored PPARgamma, retinoid X receptor, C/EBPalpha, and C/EBPbeta binding s
106 peroxisome proliferator-activated receptor, retinoid X receptor, CCAAT/enhancer binding protein, and
109 er and show that binding of the liganded VDR.retinoid X receptor directly impacts both the distal and
110 noid X Receptor alpha function and decreased Retinoid X Receptor expression was confirmed to occur 1-
111 f Fgf15 by vitamin A is mediated through the retinoid X receptor/farnesoid X receptor heterodimer and
112 imal promoter recruit retinoic acid receptor/retinoid X receptor from a distal RARE to form an enhanc
115 ormone receptor siRNA library, we identified retinoid X receptor gamma (RXRgamma) instead as being in
116 receptors, retinoic acid receptor alpha and retinoid X receptor gamma, were up-regulated in response
118 a direct transcriptional target for the LXR/retinoid X receptor heterodimer and that the ability of
119 (NRs), especially the liver X receptor (LXR)/retinoid X receptor heterodimer, as an important event i
122 TRAP220 interacted predominantly with the TR.retinoid X receptor heterodimeric pair in a ligand-depen
124 oic acid can activate retinoic acid receptor/retinoid X receptor heterodimers but not retinoid X rece
125 aling did not involve reduced binding of LXR/retinoid X receptor heterodimers to target gene promoter
126 hormone receptor (TR) homodimers, but not TR-retinoid X receptor heterodimers, to thyroid hormone res
128 s of the LXRbeta homodimer and LXRalpha:RXR (retinoid X receptor) heterodimers explains differences i
130 tor/retinoid X receptor heterodimers but not retinoid X receptor homodimers in reporter cell assays.
131 association of the ligand-binding domain of retinoid X receptor in the presence and absence of 9-cis
132 )2D3-independent interaction between VDR and retinoid X receptors in primary keratinocytes, indicatin
134 bition of IL-1beta-dependent genes by active retinoid X receptors involves antagonism of NF-kappaB si
135 of alpha-synuclein toxicity and suggest that retinoid X receptor ligands with appropriate pharmacolog
136 peroxisome proliferator-activated receptor, retinoid X receptor, liver X receptor, and activating pr
138 udes the binding of the liver X receptor and retinoid X receptor (LXR/RXR) heterodimer to the DR-4 el
140 of matrix metalloproteases, liver X receptor/retinoid X receptor, nuclear factor erythroid 2-related
141 etic ligand for the nuclear hormone receptor retinoid X receptor, on the expression of matrix metallo
142 how that expression of genes involved in the retinoid X receptor pathway are decreased with ageing in
147 ), through binding to retinoic acid receptor-retinoid X receptor (RAR-RXR) heterodimers bound at RA r
149 perfamily including retinoic acid receptors, retinoid X receptors (RAR and RXR, respectively), and pe
150 tg2 promoter and show that the element binds retinoid X receptor/RAR heterodimers in vitro, is occupi
151 on in response to 9-cis-RA as evident by the retinoid X receptor response element-luciferase assays.
153 and migration, lower retinol, and abolished retinoid X receptor/retinoid A receptor transcriptional
154 ds bound to the ligand binding domain of the retinoid X receptor reveal key structural aspects that e
156 ither BADGE nor BPA activated or antagonized retinoid "X" receptor (RXR) or PPARgamma in transient tr
158 thalenyl]-1-propenyl ) benzoic acid) and RAR/retinoid X receptor (RXR) agonist (9-cis-RA) promote exp
159 ious data demonstrate that bexarotene (Bex), retinoid X receptor (RXR) agonist, reduces soluble and i
164 served enrichment for liver X receptor (LXR)/retinoid X receptor (RXR) and farnesoid X receptor/RXR n
166 hormone receptor, which heterodimerizes with retinoid X receptor (RXR) and regulates transcription of
167 g protein (C/EBP), HNF3, and heterodimers of retinoid X receptor (RXR) and retinoic acid receptor (RA
169 ale gastropods, because of the activation of retinoid X receptor (RXR) at very low environmental conc
170 10R slightly but significantly decreased FXR/retinoid X receptor (RXR) binding affinity but enhanced
172 tor-activated receptor gamma (PPARgamma) and retinoid X receptor (RXR) by classical and nonclassical
174 oth VDREs bound the vitamin D receptor (VDR)-retinoid X receptor (RXR) complex and drove reporter gen
176 eracts with retinoic acid receptor (RAR) and retinoid X receptor (RXR) constitutively, but hormone bi
177 hat competed with a normally functioning VDR-retinoid X receptor (RXR) dimer for binding to the vitam
178 Ligands that activate the nuclear receptor retinoid X receptor (RXR) display potent anticarcinogeni
180 or, a transcriptional corepressor) from a TR*retinoid X receptor (RXR) heterodimer bound to a DR+4 th
181 multiprotein complex that assembles on a TR.retinoid X receptor (RXR) heterodimer in HeLa nuclear ex
182 ferator activated receptor-alpha (PPARalpha)/retinoid X receptor (RXR) heterodimer promotes transcrip
183 5(OH)(2)D(3)) via a vitamin D receptor (VDR)/retinoid X receptor (RXR) heterodimer that binds to two
185 These response elements directly bind FXR/retinoid X receptor (RXR) heterodimers and confer the ac
189 behavior of retinoic acid receptor (RAR) and retinoid X receptor (RXR) is revealed, and an extension
191 anisms underlying the anti-cancer effects of retinoid X receptor (RXR) ligand (rexinoid) therapy are
194 ed receptor gamma (PPARgamma) interacts with retinoid X receptor (RXR) on PPAR response elements (PPR
195 tion was achieved through the binding of PXR-retinoid X receptor (RXR) or CAR-RXR heterodimers to dir
199 orphan receptors and, in particular, of the retinoid X receptor (RXR) positioned nuclear receptors a
203 itamin D receptor (VDR) FokI AA genotype and retinoid X receptor (RXR) rs7861779 TT genotype were ass
205 sed here expressed all RA receptor (RAR) and retinoid X receptor (RXR) subtypes (as detected by North
206 mechanisms that may cause aberrations in the retinoid X receptor (RXR) subunits, RXR-alpha and RXR-be
207 binding of retinoic acid receptor (RAR) and retinoid X receptor (RXR) to a dominant site in enhancer
209 heterodimeric transcription factors with the retinoid X receptor (RXR) to regulate diverse biological
210 (FXR), which binds as a heterodimer with the retinoid X receptor (RXR) to the FXR response element (F
211 g a co-activator of the LCPUFA-sensing PPARG-retinoid X receptor (RXR) transcription complex, may inf
213 a functional heterodimer between EcR and the retinoid X receptor (RXR) upon application of the chemic
214 (NRs) function as obligate heterodimers with retinoid X receptor (RXR), allowing integration of ligan
215 receptors (PPARs) form heterodimers with the retinoid X receptor (RXR), and PPAR-gamma has been inten
217 iption factors retinoic acid receptor (RAR), retinoid X receptor (RXR), and Sp-1 exhibited >2-fold in
218 a (PPARgamma) and its heterodimeric partner, retinoid X receptor (RXR), are effective agents for the
220 did not require heterodimerization with the retinoid X receptor (RXR), indicating that FXR represses
221 by activating the retinoic acid receptor and retinoid X receptor (RXR), indirectly influencing RXR he
222 s additionally associated with regulation by retinoid X receptor (RXR), jun proto-oncogene (JUN), sin
223 ndrostane receptor, pregnane X receptor, and retinoid X receptor (RXR), modulate acetaminophen (APAP)
224 blished that as an obligate heterodimer with retinoid X receptor (RXR), PPARgamma binds directly repe
225 r hormone receptors that heterodimerize with retinoid X receptor (RXR), such as thyroid receptors, pe
227 imers and heterodimers with PPARgamma or the retinoid X receptor (RXR), thereby competing with PPARga
229 selective ablation of the nuclear receptors retinoid X receptor (RXR)-alpha and RXR-beta in mouse ep
230 f hepatocyte nuclear factor (HNF)-1alpha and retinoid X receptor (RXR)-alpha to investigate whether a
231 s controlled by the transcription regulation retinoid X receptor (RXR)-liver X receptor (LXR) system.
232 tes fundamental biological processes through retinoid X receptor (RXR)-mediated gene expression, mole
233 However, when used in combination with a retinoid X receptor (RXR)-selective ligand, tazarotene c
247 PCR analyses showed increased PPAR mRNA and retinoid X receptor (RXR)alpha mRNA expression after exp
252 soforms of retinoic acid receptors (RAR) and retinoid X receptors (RXR) with the exception of RXRgamm
255 id receptors (RAR-alpha, -beta, -gamma), and retinoid X receptors (RXR-alpha, -beta, -gamma) was perf
256 ion of retinoic acid receptor (RAR-beta) and retinoid X receptors (RXR-beta, -gamma) was significantl
258 tor-activated receptor gamma (PPARgamma) and retinoid-X receptor (RXR) ligands on AIB3(+/-)/PyMT cell
260 h activation of its heterodimer partner, the retinoid-X-receptor (RXR), was also readily detected by
262 totic effect was associated with loss of the retinoid X receptor (RXRalpha) protein in the adenocarci
265 ic acid receptors (RARs) heterodimerize with retinoid X receptors (RXRs) and bind to RA response elem
266 fatty acid sensing nuclear receptor families retinoid X receptors (RXRs) and peroxisome proliferator-
269 iferator-activated receptors (PPARs) and the retinoid X receptors (RXRs) are ligand-activated transcr
275 sms underlying neuritogenesis, we found that retinoid X receptors (RXRs) control neuritogenesis.
279 t activation of liver X receptors (LXRs) and retinoid X receptors (RXRs) inhibits apoptotic responses
280 rodimeric binding partners of PPARgamma, the retinoid X receptors (RXRs), showed additive enhancement
286 vious studies of the retinoid, bexarotene, a retinoid X receptor-specific ligand, have indicated that
287 e expression of known retinoic acid receptor/retinoid X receptor target genes, whereas GW0742 did not
288 lly targeted by bexarotene, a ligand for the retinoid X receptor that forms heterodimers with Nurr1.
289 thelium, and we identify an inhibitor of the retinoid X receptor that improves intestinal regeneratio
290 factors are the retinoic acid receptor, the retinoid X receptor, the hepatocyte nuclear factor 4alph
292 monstrated specific binding of PPARgamma and retinoid X receptor to the human and mouse pdx-1 x PPREs
293 omoted binding of the vitamin D receptor and retinoid X receptor to the promoters of osteoblastic tar
298 inoid receptors (retinoic acid receptors and retinoid X receptors), which are nuclear transcription f
300 specific nuclear retinoic-acid receptors and retinoid-X receptors, which are encoded by separate gene